Retraction: NRH:Quinone oxidoreductase 2-deficient mice are highly susceptible to radiation-induced B-cell lymphomas (Clinical Cancer Research (2009) 15 (1534-1542) DOI: 10.1158/1078-0432.CCR-08-1783);NRH:Quinone oxidoreductase 2-deficient mice are highly susceptible to radiation-induced B-cell lymphomas

Clinical Cancer Research

Volumn 15, Issue 5, 2009, Pages 1534-1542

  Iskander, Karim ^a   Barrios, Roberto J ^b   Jaiswal, Anil K ^a,c  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

^b HOUSTON METHODIST HOSPITAL   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL PROTEIN; NRH QUINONE OXIDOREDUCTASE 2; PROTEIN BAX; PROTEIN P53; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; B LYMPHOCYTE; BLOOD SAMPLING; BONE MARROW; CANCER PREVENTION; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GAMMA RADIATION; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; KIDNEY; LIVER; LUNG; LYMPH NODE; MALE; MOUSE; MYELOPROLIFERATIVE DISORDER; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DEGRADATION; PROTEIN FUNCTION; SALIVARY GLAND; SPLEEN; T LYMPHOCYTE; THYMUS; WILD TYPE;

EID: 63449114541     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-18-2878     Document Type: Erratum

References (27)

1. Radjendirane V, Joseph P, Jaiswal AK. Gene expression of DT-diaphorase (NQO1) in cancer cells. In: Forman HJ, Cadenas E, editors. Oxidative stress and signal transduction. New York: Chapman & Hall; 1997. p. 441-75.
2. Ross D, Kepa JK, Winski SL, Beall HD, Anwar A, Siegel D. NAD(P)H:quinone oxidoreductase1 (NQO1): chemoprotection, bioactivation, gene regulation and genetic polymorphism. Chem Biol Interact 2000;129:77-97.
3. Wu K, Knox R, Sun XZ, et al. Catalytic properties of NAD(P)H:quinone oxidoreductase2 (NQO2), a dihydronicotinamide riboside dependent oxidoreductase. Arch Biochem Biophys 1997;345:221 -8.
4. Knox RJ, Jenkins TC, Hobbs SM, Chen S, Melton RG,Burke PJ.Bioactivation of 5-(aziridin-1-yl)-2,4-dinitrobenzamide (CB 1954) by human NAD(P)H: quinone oxidoreductase 2: a novel co-substrate-mediated antitumor prodrug therapy. Cancer Res 2000;60:4179-86.
5. Zhao Q,Yang XL, HoltzclawWD,Talalay P. Unexpected geneticand structural relationships ofa long-forgotten flavoenzyme to NAD(P)H:quinone reductase (DT-diaphorase). ProcNatl Acad Sci U S A 1997;94: 1669 -74.
6. Foster CE, Bianchet MA, Talalay P, Zhao Q, Amzel LM. Crystal structure of human quinone reductase type 2, a metalloflavoprotein. Biochemistry 1999;38: 9881 -6.
7. Gong X, Kole L, Iskander K, Jaiswal AK. NRH:quinone oxidoreductase 2 and NAD(P)H:quinone oxidoreductase 1 protect tumor suppressor p53 against 20S proteasomal degradation leading to stabilization and activation of p53. Cancer Res 2007;67:5380-8.
8. Asher G, Loten J, Kama R, Sachs L, Shaul Y. NQO1 stabilizes p53 through a distinct pathway. Proc Natl Acad Sci U S A2002;99:3099 -104.
9. Jaiswal AK. Regulation of antioxidant response element-dependent induction of detoxifying enzyme synthesis. Method Enzymol 2004;378:221 -38.
10. Garate M, Wong RP, Campos EI, Wang Y, Li G. NAD(P)H:quinone oxidoreductase 1 inhibits the pro-teasomal degradation of the tumour suppressor p33(ING1b). EMBO Rep 2008;9:576 -81.
11. Long DJ, Iskander K, Gaikwad A, et al. Disruption of dihydronicotinamide riboside:quinone oxidoreductase 2 (NQO2) leads to myeloid hyperplasia of bone marrow and decreased sensitivity to menadione toxicity. J Biol Chem 2002;277:46131 -9.
12. Radjendirane V, Joseph P, Lee H, et al. Disruption of the DTdiaphorase (NQO1) gene in mice leads to increased menadione toxicity. J Biol Chem 1998; 273:7382-9.
13. Long II DJ, Gaikwad A, Multani A, et al. Disruption of the NAD(P)H:quinone oxidoreductase 1 (NQO1) genein mice causes myelogenous hyperplasia. Cancer Res 2002;62:3030-6.
14. IskanderK,LiJ,HanS,ZhengB,JaiswalAK.NQO1 and NQO2 regulation of humoral immunity and autoimmunity. J Biol Chem 2006;281:19798-808.
15. Iskander K, Paquet M, Brayton C, Jaiswal AK. Deficiency of NRH:quinone oxidoreductase 2 increases susceptibility to 7,12-dimethybenz(a) anthracene and benzo(a)pyrene-induced skin carcinogenesis. Cancer Res 2004;64:5925 -8.
16. Long II DJ,Waikel RL,Wang X, PerlakyL, Roop DR, Jaiswal AK. NAD(P)H:quinone oxidoreductase 1 deficiency increases susceptibility to benzo(a) pyrene-induced mouse skin carcinogenesis. Cancer Res 2000;60:5913-5.
17. Long DJ, Waikel RL, Wang XJ, Roop DR, zJaiswal AK. NAD(P)H:quinone oxidoreductase 1 deficiency and increased susceptibility to 7,12- dimethylbenz[a]-anthracene-induced carcinogenesis in mouse skin. J Natl Cancer Inst 2001;93:1166-70.
18. Iskander K, Gaikwad A, Paquet M, et al. Lower induction of p53 and decreased apoptosis in NQO1-null mice leads to increased sensitivity of chemical-induced carcinogenesis. Cancer Res 2005;65:2054-8.
19. Iskander K, Barrios RJ, Jaiswal AK. Disruption of NAD(P)H:quinone oxidoreductase 1 gene in mice leads to radiation induced myeloproliferative disease. Cancer Res 2008;68:7915-22.
20. Jaiswal AK, Bell DW, Radjendirane V, Testa JR. Localization of human NQO1 gene to chromosome 16q22 and NQO2-6p25 and associated polymorphism. Pharmacogenetics 1999;9:413-8.
21. Ostrousky O, Meged S, Loewenthal R, et al. NQO2 gene is associated with clozapine-induced agranulocytosis. Tissue Antigens 2003;62:483-91.
22. Harada S, Fujii C, Hayashi A, Okhoshi N. An association between idiopathic Parkinson's disease and polymorphisms of phase II detoxification enzymes: glutathione S-transferase M1 and quinone oxidoreductase 1 and 2. Biochem Biophys Res Commun 2001;288:14502-8.
23. Wang W, Jaiswal AK. Sp3 repression of polymorphichuman NRH:quinone oxidoreductase 2 gene promoter. Free Radic Biol Med 2004;37: 1231 -43.
24. Das A,KoleL, WangL, Barrios R, Moorthy B, Jaiswal AK. BALT development and augmentation of hyperoxiclung injury in mice deficient in NQO1 and NQO2. Free Radic Biol Med 2006;40: 1843-56.
25. Krishna G, Nath J, Ong T. Murine bone marrow culture system for cytogenetic analysis. Mutat Res 1986;164:91-9.
26. Kemp CJ, Wheldon T, Balmin A. p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nat Genet 1994;8:66-9.
27. Walter MJ, Park JS, Ries RE, et al. Reduced Pu.1 expression causes myeloid progenitor expansion and increased leukemia penetrance in mice expressing PML-RARa. ProcNatl Acad Sci U S A 2005;102: 12513-8.